From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
The broader markets displayed divergent trend with BSE Midcap index closed up by 0.6% and Smallcap index closed down by 0.4%, respectively. Benchmark share indices snapped a two-day winning streak......
Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.Apart from Glenmark, Sun......
Sun, Lupin and Dr Reddy’s to lead here, with domestic formulations expected to rebound after Sept quarter. After posting a strong 20-plus per cent growth in the March quarter, top Indian......
Foreign institutional investors now hold at least 10 per cent stake in one in every seven major Indian companies. These companies are listed under the A, B1, B and S groups on the bourses.There are......